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ALIX plays a role in nucleocapsid release during viral
infection, as does lysobisphosphatidic acid (LBPA).
However, the mechanism remains unclear. Here we
report that LBPA is recognized within an exposed
site in ALIX Bro1 domain predicted by MODA, an
algorithm for discovering membrane-docking areas
in proteins. LBPA interactions revealed a strict
requirement for a structural calcium tightly bound
near the lipid interaction site. Unlike other calcium–
and phospholipid-binding proteins, the all-helical
triangle-shaped fold of the Bro1 domain confers
selectivity for LBPAvia apair of hydrophobic residues
in a flexible loop, which undergoes a conformational
change upon membrane association. Both LBPA
and calcium binding are necessary for endosome
association and virus infection, as are ALIX ESCRT
binding and dimerization capacity. We conclude
that LBPA recruits ALIX onto late endosomes via the
calcium-bound Bro1 domain, triggering a conforma-
tional change in ALIX to mediate the delivery of viral
nucleocapsids to the cytosol during infection.
INTRODUCTION
After internalization, activated signaling receptors are sorted into
lumenal invaginations of the early endosome membrane, which
are pinched off as free cargo-containing vesicles (Gruenberg
and Stenmark, 2004). These multivesicular regions detach and
become multivesicular endosomes or bodies, which are trans-
ported to and fuse with late endosomes. Eventually, intralumenal
vesicles (ILVs) and their cargo are delivered to lysosomes and
degraded.Viruseshijack thisdoorway into thecell throughapoorly
understood process that is mediated by ALIX, LBPA (or BMP
[bis(monoacylglycero)phosphate]), and the ESCRT machinery.
The sorting of activated signaling receptors into forming ILVs
is achieved by ESCRT complexes, including ESCRT-I and -II,
which may induce membrane invaginations, and ESCRT-III,
which may catalyze membrane fission (Hurley and Hanson,
2010; Raiborg and Stenmark, 2009). ESCRT-I and ESCRT-III
are also involved in two processes topologically equivalent to
ILV formation, cytokinesis and virus budding at the plasmamem-364 Developmental Cell 25, 364–373, May 28, 2013 ª2013 Elsevier Inbrane. Similarly, ALIX, which interacts with the ESCRT-I subunit
TSG101 (Strack et al., 2003; von Schwedler et al., 2003) and the
ESCRT-III subunit CHMP4 (Fisher et al., 2007; Usami et al.,
2007), is also required during cytokinesis and virus budding at
the plasma membrane. Unlike ESCRTs, however, ALIX does
not play a role in ubiquitin-dependent lysosome targeting of
the EGF receptor (Cabezas et al., 2005; Doyotte et al., 2008;
Luyet et al., 2008; Schmidt et al., 2004), but perhaps in the
ubiquitin-independent, ESCRT-III-dependent sorting of the
GPCR PAR1 (Dores et al., 2012).
We found that ALIX interacts with the unconventional phos-
pholipid LBPA (Matsuo et al., 2004), which is detected only
in late, but not early, endosomes, and is abundant in ILVs
(Kobayashi et al., 1999). Much like ALIX, LBPA plays no role in
signaling receptor trafficking to lysosomes (Luyet et al., 2008).
Instead, both ALIX and LBPA play a crucial role in the penetration
of somepathogenic agents into host cells, including anthrax toxin
(Abrami et al., 2004), vesicular stomatitis virus (VSV) (Le Blanc
et al., 2005; Luyet et al., 2008), Lassa virus, and lymphocytic
choriomeningitis virus (Pasqual et al., 2011). Although the mech-
anism remains to be elucidated, it has been proposed that
anthrax lethal factor and VSV RNA would first be released into
the ILV lumen in order to reach late endosomes without encoun-
tering their degradative environment (Abrami et al., 2004; Le
Blanc et al., 2005). There, ILV backfusion with the limiting mem-
brane would ensure toxin or RNA release into the cytoplasm in
a process controlled by LBPA, ALIX, and ESCRTs. This LBPA-
and ALIX-dependent endosomal way-out may be used by
endogenous cargo in transit toward destinations other than the
lysosomes (Chevallier et al., 2008; Kobayashi et al., 1998, 1999;
Le Blanc et al., 2005; Luyet et al., 2008; Pasqual et al., 2011).
Here, we elucidate the molecular mechanism by which ALIX
mediates viral penetration through recognition of LBPA, a unique
lipid foundwithin lateendosomes.Weconclude thatLBPArecruits
ALIX onto late endosomes in a process controlled by calcium,
which may trigger ALIX conformational changes, and that this
mechanism in turn controls ALIX functions in viral infection.
RESULTS
ALIX-Membrane Interactions Are LBPA and Calcium
Dependent
Because ALIX may be involved in regulating LBPA functions
(Matsuo et al., 2004), we expressed and purified to homogeneity
(Figure 1A; Figures S1A and S1B available online) ALIX’sc.
Figure 1. ALIX-Membrane Interactions are
LBPA and Calcium Dependent
(A) Schematic representation of ALIX protein
domains.
(B) Recombinant ALIXBro1 and ALIXV were incu-
bated with liposomes (DOPC/DOPE/PI/LBPA;
[5:2:1:2 mol]) for 2 hr at 4C. The liposome-bound
protein was then separated from free protein by
floatation in sucrose gradients. Fractions were
collected and analyzed by western blotting: (Lip)
50% of the fraction containing liposomes; (35%)
5.5% of the 35% sucrose cushion; (load) 12% of
the fraction containing the load; (Std) 0.25 mg of
the corresponding recombinant protein as stan-
dard. With LBPA present at the same level as in
late endosomes (Kobayashi et al., 1998), 5% of
total ALIXBro1 was found associated with lipo-
somes after floatation, consistent with the char-
acteristically weak and dynamic nature of protein-
lipid interactions.
(C and D) Liposome binding of recombinant
ALIXBro1 was analyzed as in (B), but in the
presence of the indicated concentrations of free
calcium (C) and quantified in (D).
(E) A typical calcium titration curve monitored by
ITC (upper panel) shows calcium binding to
ALIXBro1. The curve fit is illustrated in the lower
panel, revealing that approximately one calcium
atom was bound per ALIXBro1 molecule, and the
thermodynamic values obtained from the curve fit
are: n = 1.58 ± 0.06, K = 2.14 3 106 ± 7.33 3
105 M1, DH = 2,892 ± 143.4 cal/mol, DS =
39.2 cal/mol/deg, KD = 467 ± 160 nM.
(F) Recombinant ALIXBro1 was incubated with
liposomes containing LBPA as in (B) or not (DOPC/
DOPE/PI; [7:2:1 mol]). Protein binding to lipo-
somes was analyzed as in (B).
(G) Data in (F) were quantified and are expressed
as a percentage of LBPA values.
(H) Binding of ALIXBro1 to liposomes containing 10
mol% of the indicated phospholipids in 90 mol%
DOPC was analyzed as in (B).
(I) Data in (H) were quantified and are expressed
as in (G).
All quantifications show means (±SEM) of three
independent experiments. See also Figure S1.
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recognition. The recombinant proteins were incubated with
liposomes of the same phospholipid composition as late endo-
somes, including 20 mol% LBPA (Kobayashi et al., 1999), and
membrane binding was measured in a step sucrose gradient
after liposome floatation. The N-terminal Bro1 domain, but not
the middle V domain, copurified with liposomes (Figure 1B),
and this interaction specifically required the presence of LBPADevelopmental Cell 25, 364–(Figures 1F and 1G). While screening for
optimal binding conditions, we found
that membrane interaction requires
calcium—anunexpected finding because
ALIX does not contain any known
calcium-binding motif. Liposome binding
was enhanced with increasing calcium
concentrations, with an apparent EC50
z100 nM, whereas without calcium, virtually no binding could
be detected (Figures 1C and 1D). Calcium was specifically
required for ALIX-membrane interactions, because it could not
be replacedwithmagnesium (FigureS1C). Unless otherwise indi-
cated, 2 mM calcium was present in all subsequent experiments.
Isothermal titration calorimetry (ITC) measurements showed
that approximately one calcium atom is bound per ALIXBro1 mol-
ecule, and ALIXBro1 binds calcium with a KD of 467 ± 160 nM373, May 28, 2013 ª2013 Elsevier Inc. 365
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ALIX Lipid-Binding Module in Viral Infection(Figure 1E)—a value in the same range as calcium-dependent
ALIXBro1 binding to liposomes (Figures 1C and 1D). These values
are in the range of cytosolic-free calcium concentrations under
resting conditions. Hence, calcium binding is unlikely to be
controlled by calcium-dependent signaling. Calcium can bind
to the Bro1 domain while free in solution (Figure 1E) and is also
required for membrane interaction (Figures 1C and 1D). It may
thus play a structural role by stabilizing the ALIX conformation
competent to bind membranes.
ALIXBro1 binding to membranes required LBPA, a negatively
charged lipid, and binding was reduced to background when
LBPA was omitted (Figures 1F and 1G). However, other nega-
tively charged phospholipids did not substitute for LBPA (Figures
1H and 1I). Thus, ALIX interactions with LBPA are not simply due
to the presence of a negative charge on the lipid headgroup.
ALIX recruitment to membranes appears to be mediated by its
calcium-bound Bro1 domain specifically recognizing LBPA. As
such, the ALIX Bro1 domain is fundamentally different from other
membrane binding domains—none of which exhibits LBPA
binding.
Identification of the Membrane Interaction Site of ALIX
The Bro1 domain of ALIX does not share any obvious homol-
ogies to known membrane interaction sites. For de novo
prediction we made use of a newly developed membrane
optimal docking area (MODA) program. This algorithm identifies
protein surface patches, which serve as privileged sites for lipid
interactions, and has been trained against experimentally vali-
dated membrane binding sites (I.K. and R.A., unpublished
data; Kufareva and Abagyan, 2009).
Using the available protein structure of ALIX, a major mem-
brane interaction site was predicted on the convex surface of
the Bro1 domain, corresponding to 101-KGSLFGGSVK-110
and 232-QYKD-235, with two hydrophobic residues L104 and
F105 being prominently exposed at the extremity of the former
flexible loop (Figures 2A and 2B). These two residues are flanked
by glycine residues and by basic lysine residues at position 101
and 110 (Figure 2B)—a signature feature of some membrane
insertion loops, thus further strengthening the MODA prediction.
The membrane interaction site predicted in the Bro1 domain of
ALIX is conserved in vertebrates that contain LBPA, and is not
found in yeast and plants (Figure S2A) in which LBPA has not
been detected. Furthermore, the site is not found in functionally
unrelated proteins containing a Bro1 domain (Figure S2B).
Mutation of the exposed hydrophobic residues L104 and F105
(Figure 2B) to glutamines (QQ mutant) abolished membrane in-
teractions in our liposome-binding assay (Figures 2C and 2D).
Membranes interactions were also abolished by mutation of
the two lysine residues 101 and 110 (Figures 2C and 2D), which
flank L104 and F105 on either side of the loop and therefore
seem well positioned to interact with the negatively charged
head groups of membrane phospholipids (Figure 2B). The
observed effects of the mutations were not due to improper
folding, because the QQ, K101A, and K110A mutants still inter-
acted with CHMP4 (Figure 2G). Conversely, the I212D mutation
in the CHMP4 binding site abrogated ALIX-CHMP4 interaction
(Fisher et al., 2007; Usami et al., 2007) (Figure 2G), but not lipo-
some binding, indicating that the functional effect of the QQ,
K101A, and K110A mutations were specific (Figures 2C and 2D).366 Developmental Cell 25, 364–373, May 28, 2013 ª2013 Elsevier InMoreover, a peptide of ALIX’s wild-type membrane-
interacting loop (93-FTWKDAFDKGSLFGGSVK-110) competed
with ALIXBro1 for membrane interaction, whereas the cor-
responding QQ peptide (93-FTWKDAFDKGSQQGGSVK-110)
or a scrambled version of the wild-type peptide
(GDKVKSTKWFSAFGDFGL) had no effect (Figures 2E and 2F).
By contrast, the peptide of ALIX’s wild-type membrane-interact-
ing loophadnoeffect on themembraneassociation of theMABP-
myc (MVB12-associated b-prism) domain of MVB12B (Figures
2Eand2F),which is foundon thesamemembranesasALIX in vivo
and which binds negatively charged phospholipids (Boura and
Hurley, 2012), but shows no preference for LBPA (Figure S1D).
These data indicate that the loop identified by the MODA soft-
ware in ALIXBro1 is the dominant contributor to direct binding of
LBPA-containing membranes.
Identification of the Calcium Interaction Site
Comparison with the structures of 563 calcium-binding proteins
in the Protein Data Bank (PDB) yielded a possible calcium coor-
dination site involving D97 and D178, which are located close to
the LBPA interaction site in ALIXBro1 (Figures 2A and 2B). Muta-
tion of residue D178 to alanine significantly raised the calcium
concentration required for membrane binding (Figure 3A),
because membrane interactions were reduced to background
even at 0.3 mM free calcium—a concentration at which wild-
type ALIXBro1 showed almost complete saturation (Figures 1D
and 3A). A similar, although less pronounced, effect was
observed with ALIXBro1 carrying the D97A mutation (Figure 3A).
The role of D97 and D178 seems specific, because membrane
binding was not affected by mutation of D314 and D316
(Figure 3A), which are also exposed on the protein surface
(Figure 2A). Furthermore, the I212D mutant in the CHMP4 bind-
ing site (Figure 2G) retains calcium-dependent membrane bind-
ing capacity (Figure 3A).
Hence, calcium is likely to be coordinated by residues D97 and
D178, at a site positioned to form a structured linker or hinge for
themembrane interacting loopwhere it extends from the single b
sheet. The structure of this site, together with the observations
that ALIX binds calcium with a relatively high affinity in solution
(Figure 1E) and while on membranes (Figures 1C and 1D), sug-
gests that calcium induces a conformation in the b1-b2 loop
that is favorably predisposed for membrane interactions.
ALIX Interacts Tightly with Membranes
A treatment with 2 M NaCl released bound ALIXBro1 from mem-
branes (Figures 3B and 3C), indicating that electrostatic interac-
tions are involved in membrane association. This is consistent
with the role of the positively charged lysine residues 101 and
110 flanking the LBPA interaction site (Figures 2C and 2D) and
the negative charge of LBPA. However, as other negatively
charged lipids do not substitute for LBPA (Figures 1H and 1I),
electrostatic interactions may enhance but do not determine
binding. ALIXBro1 was not released by a carbonate wash at pH
11 (Figures 3B and 3C), a classic test that favors hydrophobic
interactions (Fujiki et al., 1982), suggesting that the protein is
associated with membranes via a combination of electrostatic
and hydrophobic interactions. Although calcium chelation pre-
vented ALIXBro1 membrane recruitment (Figures 1C and 1D), it
dislodged little membrane-bound ALIXBro1 (Figures 3B and 3C),c.
Figure 2. Identification of the Membrane Interaction Site of ALIXBro1
(A) Ribbon model of ALIXBro1 using the atomic coordinates derived from the X-ray diffraction analysis (PDB ID code: 2R03) (Zhai et al., 2008). The N and C termini
of the Bro1 domain aremarked with N and C, respectively. Themembrane interacting residues predicted byMODA are shown in brown (101-KGSLFGGSVK-110)
and orange (232-QYKD-235). Side chains of residues mutagenized in this study are indicated as sticks, including i) I212 involved in CHMP4 interactions (Fisher
et al., 2007; Usami et al., 2007; ii) L104, F105, K101, and K110 inmembrane binding, iii) D97 and D178 in calcium coordination, and iv) D314 and D316 as controls.
(B) Higher magnification view of the membrane-interacting region.
(C) The liposome-binding capacity of ALIXBro1, ALIXBro1I212D, ALIXBro1QQ, ALIXBro1K101A, and ALIXBro1K110A was analyzed as in Figure 1B.
(D) Data in (C) were quantified and are expressed as a percentage of the WT values.
(E) ALIXBro1 or the myc-tagged MABP domain of MVB12B was incubated with liposomes containing 20% LBPA or PS, respectively, in the presence of 100-fold
molar excess WT, QQ, or scrambled peptide. Membrane binding of ALIXBro1 was analyzed as in Figure 1B.
(F) Data in (E) were quantified and are expressed as a percentage of a control without peptide.
(G) Extracts prepared from cells expressing CHMP4B-myc were incubated with ALIXBro1-GST or with the same mutants as in (C) and (D). These were then
retrieved using glutathione Sepharose beads and analyzed by western blotting using anti-myc antibody. First lane: 1/30 of the starting materials.
All quantifications show means (±SEM) of at least three independent experiments. See also Figure S2.
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Figure 3. Characterization of ALIX-Mem-
brane Interactions
(A) Liposome binding was analyzed as in Fig-
ure 1B for ALIXBro1, ALIXBro1I212D, ALIXBro1D97A,
ALIXBro1D178A, ALIXBro1D314A, and ALIXBro1D316A in
the presence of 0, 0.1, 0.3, and 2 mM free calcium.
Binding is expressed as a percentage of the value
obtained with 2 mM free calcium.
(B) ALIXBro1 was first preincubated with liposomes
for 2 hr as in Figure 1B. The reaction mixture was
then adjusted to 2MNaCl, 0.1M carbonate pH 11,
10 mM EDTA, or 2% NP40. ALIXBro1 remaining on
the membrane was analyzed after floatation as in
Figure 1B.
(C) Quantification of membrane-bound ALIXBro1 in
(B). Binding is expressed as a percentage of the
control (Ctrl).
(D) After binding to liposomes, membrane-bound
and free ALIXBro1 were separated as in Figure 1B,
and each was extracted with TX-114. Lanes 1–4:
0.25 mg ALIXBro1 as standard (Std); complete
mixture before phase separation (input); water
(Wat) and detergent (Det) phases after extraction.
(E) Quantification of TX-114 extraction in (D), ex-
pressed as a percentage of the total protein in
each condition.
(F) Recombinant ALIXBro1 and ALIXBro1QQ were
incubated in the presence or absence of 2.5 mM
calcium and liposomes lacking LBPA or contain-
ing 20 mol% LBPA with or without 10% BrPC.
Liposomes with membrane-bound protein were
recovered by floatation and Trp fluorescence was
measured. If indicated, 150 mM KI was added
prior to the measurements.
All quantifications show means (±SEM) of three
independent experiments. See also Figure S3.
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Moreover, when liposomes with bound ALIXBro1 were extracted
with Triton X-114, 50% of membrane-bound ALIXBro1 fraction-
ated like a membrane protein into the detergent phase (Bordier,
1981), whereas 90% of the free protein was found in the water
phase (Figures 3D and 3E). In contrast, ALIXBro1 was readily
released after membrane solubilization with the detergent
NP40 (Figures 3B and 3C). Our results show that ALIXBro1
exhibits two distinct states, i.e., free in solution or membrane-368 Developmental Cell 25, 364–373, May 28, 2013 ª2013 Elsevier Inc.bound (Figure 3), and that membrane
association involves both electrostatic
and hydrophobic interactions—consis-
tent with the critical role of exposed
hydrophobic residues and their flanking
basic residues (Figure 2B). We conclude
that a conformational change may allow
ALIXBro1 to insert into the bilayer during
LBPA engagement.
Membrane-Bound ALIX Penetrates
the Lipid Bilayer
We used Trp fluorescence to measure
membrane association, because Trp 95
is near the interaction site. The signal
was abolished without calcium, as itwas with calcium but with liposomes lacking LBPA (Figure 3F).
In addition, no signal was detected with the QQ mutant, con-
sistent with its inability to bind LBPA-containing liposomes (Fig-
ure 3F; see also Figures 2C and 2D). The fluorescence intensity
correlated well with ALIXBro1 membrane-association (Figure 3F,
western blot), indicating that the signals reflect the calcium-
dependent association of ALIXBro1 with liposomes containing
LBPA. Strikingly, ALIXBro1 fluorescence was significantly
quenched when LBPA-containing liposomes were spiked with
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ALIX Lipid-Binding Module in Viral Infectionbrominated lipids, without affecting ALIXBro1 membrane-associ-
ation (Figure 3F). The remaining signal was presumably emitted
by a second Trp residue at position 6 of the mouse recombinant
ALIXBro1 protein. Quenching likely occurred from within the
bilayer, because no quenching was observed with a buffer con-
taining KI (Figure 3F). This lack of effect could not be due to the
Trp residue being hidden from the solution on the side of the
protein bound to the bilayer, because KI had no effect on Trp
fluorescence in solution (Figure S3A).
Altogether, our data indicated that calcium induced a con-
formation predisposed for membrane binding and that the
conformational change was complete upon interaction with
LBPA. Calcium binding, however, did not alter the overall struc-
ture of ALIXBro1, because it had little, if any, effect on the protein
shape analyzed by SAXS (Figure S3E), Trp fluorescence (Fig-
ure S3B) or circular dichroism (Figures S3C and S3D). We
conclude that binding to LBPA-containing membranes causes
partial bilayer penetration of the mobile hydrophobic loop,
resulting in tight membrane association of ALIXBro1.
Endosome Association Is Impaired by Mutations in the
LBPA- and Calcium-Interaction Sites
Conventional immunofluorescence is of limited use to visualize
ALIX on endosomes because the protein is predominantly cyto-
solic (Vito et al., 1999) (Figure S3F). ALIX, however, was shown to
undergo dimerization (Pires et al., 2009). We thus combined live-
cell microscopy with split YFP complementation (Remy and
Michnick, 2007), where N- and C-terminal halves of YFP are
fused to ALIX lacking the proline-rich domain (Pires et al.,
2009). After transfection of the split ALIXDPRD-YFP constructs,
the staining was cytosolic (Figure 4A) as expected (Figure S3F).
At low expression levels, ALIXDPRD-YFP also colocalized with the
late endosomal marker CD63 (Figure 4A), in agreement with the
distribution of its partner phospholipid LBPA (Kobayashi et al.,
2002). Strikingly, the ALIXDPRDQQ-YFP mutant showed a diffuse,
typically cytosolic staining pattern, as did the constructs carrying
the K101A or K110A mutation as well as the D97A or D178A
mutation—but not the control D316A mutation (Figures 4A–4C).
Like the ESCRT-I and ESCRT-III complexes, ALIX is not only
present on endosomes but is also found at the midbody during
cytokinesis, where it is recruited by CEP55 (Carlton et al.,
2008; Morita et al., 2007). As expected, ALIX labeled the
midbody of mock-treated but not CEP55-depleted cells (Fig-
ure S4G). The QQ mutant was also found at the midbody (Fig-
ure S4G), as was the I212D mutant in the ESCRT-III binding
site (Carlton et al., 2008). Hence, mutation of the hydrophobic
L104 and F105 residues, which are involved in association with
LBPA-containingmembranes in vitro and late endosomes in vivo,
does not affect the LBPA-independent association of ALIX to the
midbody.
After subcellular fractionation by floatation in step sucrose
gradients (Huber et al., 2000), we found that membrane associ-
ation of the full-length protein with a defective LBPA-interaction
site (ALIXQQ, ALIXK101A, and ALIXK110A) was severely impaired,
when compared to wild-type (Figures 4D and 4E). Similarly,
membrane association of full-length proteins harboring the
D97A or D178A mutation, but not the control mutations D314A
and D316A, was also strongly impaired compared to wild-type
(Figures 4D and 4E). These differences in membrane associationDevedid not reflect different expression levels (Figures 4D and 4E).
The effects were specific, because mutation of the CHMP4-
binding site (ALIXI212D) only marginally, if at all, affected
membrane association (Figures 4D and 4E). Altogether, these
observations indicate that the flexible loop identified in ALIX
with the MODA software is necessary for binding to LBPA-
containing bilayers in vitro and to late endosomes in vivo, as
are the flanking basic residues K101 and K110.
Moreover, our data with the D97A andD178Amutants (Figures
4D and 4E) show that the putative calcium-coordinating residues
next to the LBPA site play a consistent role in calcium-depen-
dent liposome binding in vitro and endosome localization in vivo.
This also defines the Bro1 domain’s calcium-dependent LBPA
recognition function as being responsible for the selective
recruitment to the late endosome.
ALIX Functions in Viral Infection Require Intact LBPA-,
Calcium-, and ESCRT-Interaction Sites
Given the involvement of ALIX and LBPA in the delivery of viral
nucleocapsids to the cytoplasm during viral infection (Le Blanc
et al., 2005; Luyet et al., 2008; Pasqual et al., 2011), we investi-
gated whether ALIX binding to LBPA is necessary for VSV
infection. After virus binding to the cell surface on ice at low
multiplicity of infection (1.0 moi), followed by a 3 hr incubation
at 37C, z50% of the cells were infected, as quantified by
measuring viral G-glycoprotein expression (Figure 5A). A partial
knockdown of ALIX (z80%) with siRNAs (Figure 5C) reduced
infection toz60%of the control (Figure 5B, quantification in Fig-
ure 5E), in agreement with previous observations (Le Blanc et al.,
2005; Luyet et al., 2008). This inhibition was specific, because
infection could be restored by overexpression of RNAi-resistant
wild-type ALIX (Figure 5E)—an effect not due to some gain-of-
function phenotype, because overexpression alone did not
affect infection (Figure 5D).
In the ALIX knockdown background, infection could not be
restored by reexpression of the ALIXI212D mutant (Figure 5E),
which binds LBPA-containing membranes (Figures 2 and 4),
but not ESCRT-III (Figure 2G). Infection was not efficiently
restored by ALIX Bro1 domain either, which binds bilayers con-
taining LBPA (Figure 1), but cannot dimerize or interact with the
ESCRT-I subunit TSG101 or other partners. Similarly, reexpres-
sion of ALIXDBro1, which lacks both membrane interaction and
CHMP4-binding sites did not rescue infection (Figure 5E). These
observations cannot be accounted for by differences in the
expression levels (Figures S4C and S4D). Similarly, none of the
mutants affected VSV infection when overexpressed much like
the wild-type protein (Figure 5D). Remarkably, we find that a
monomeric mutant ALIXmono (Pires et al., 2009) failed to restore
infection after ALIX knockdown (Figure S4B), whereas, as a con-
trol, another mutant in the same region that can still form dimers
(ALIXdimer) (Pires et al., 2009) partially restored viral infection (Fig-
ure S4B). Again, VSV infectionwas not affected after overexpres-
sion of any of the mutant (Figure S4A) and effects are not due to
differences in expression levels (Figures S4C and S4D). Mem-
brane association of ALIXdimer, like ALIXmono, was essentially
not impaired (Figures S4E and S4F).
In marked contrast to the wild-type protein, mutants defective
in LBPA recognition (ALIXQQ) failed to restore viral infection after
ALIX knockdown (Figure 5E), as did mutants of the lysinelopmental Cell 25, 364–373, May 28, 2013 ª2013 Elsevier Inc. 369
Figure 4. Endosome Association Is Impaired in Membrane- and Calcium-Binding Mutants
(A–C) HeLa cells were cotransfected with CD63-mRFP (red) and with split ALIXDPRD-YFP containing the indicated mutations (green) and visualized by live-cell
microscopy 16 hr after transfection; (A) wild-type (WT) and control D316A mutant; (B) membrane binding mutants, QQ, K101A and K110A; (C) calcium binding
mutants D97A and D178A. Scale bars represent 10 mm.
(D) Myc-tagged ALIX full-length mutants were transiently overexpressed in HeLa cells and postnuclear supernatant (PNS) and light membrane fractions (LM)
containing endosomes were prepared and analyzed by western blotting using the indicated antibodies. Antibodies to tubulin (Tub) and RAB7 were used as equal
loading marker.
(E) Quantification of myc-ALIX mutants in LM (D) expressed as a percentage of WT protein.
Means (±SEM) of at least three independent experiments are shown. See also Figure S5.
Developmental Cell
ALIX Lipid-Binding Module in Viral Infectionresidues that flank the LBPA recognition site (ALIXK101A and
ALIXK110A) or of the calcium binding site (ALIXD97A and
ALIXD178A). Overexpression of these mutants had no effect (Fig-
ure 5D) and expression levels were comparable (Figures S4C
and S4D). Together these data demonstrate that ALIX calcium-
dependent LBPA recognition is necessary for the function of
the protein in viral infection. In addition, these data demonstrate
that ALIX interactions with ESCRT subunits are also necessary
for viral infection, in good agreement with findings from us (Luyet
et al., 2008) and others (Pasqual et al., 2011) that viral infection
depends on both ALIX and ESCRTs. Our observations also sug-370 Developmental Cell 25, 364–373, May 28, 2013 ª2013 Elsevier Ingest that ALIX dimerization plays an important role not only in HIV
budding (Pires et al., 2009), but also in VSV infection. Finally, our
data argue that ALIX binding to LBPA-containing membranes is
required upstream from ALIX dimerization and engagement of
the ESCRT machinery.
DISCUSSION
Mechanism of ALIX Calcium-Dependent Lipid Binding
We show that ALIX interacts with LBPA-containing membranes
via a lipid-binding motif within a flexible loop on the convexc.
Figure 5. ALIX Functions in VSV Infection
Require Active LBPA, Calcium, and ESCRT
Interaction Sites
(A and B) HeLa cells that had been pretreated with
control siRNAs (A) or anti-ALIX siRNAs (B) were
incubated for 1 hr on ice with VSV at low moi (1.0)
and then for 3 hr at 37C to allow infection to
proceed. After fixation and permeabilization, in-
fected cells were visualized using anti-VSV-G
antibody (red) and nuclei using DAPI (blue).
(C) Knockdown efficiency of RNAi treatment was
analyzed bywestern blotting. Antibodies to tubulin
(Tub) were used as equal loading marker.
(D and E) HeLa cells were first transfected with
control (D) or anti-ALIX siRNAs (E), as in (A) and (B),
respectively, and 56 hr later with DNA coding for
the indicated RNAi-resistant versions of myc-
tagged ALIX mutants or wild-type (mock: empty
vector). Sixteen hours later, the cells were infected
with VSV as in (A) and (B), and processed for
immunofluorescence using anti-VSV-G antibody
and anti-myc antibody to visualize infected and
ALIX-myc expressing cells, respectively. Virus
infection was scored in cells expressing wild-type
ALIX or each mutant, and the data are expressed
as a percentage of the value obtained with control
(mock transfected) cells.
Means (±SEM) of more than three independent
experiments are shown. Samples from the same
experiments were analyzed by SDS gel elec-
trophoresis followed by western blotting with
anti-myc antibodies to determine the levels of
expression of each protein (Figures S4C and S4D).
See also Figure S5.
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interactions require calcium binding, presumably to an uncon-
ventional site in the vicinity of the lipid-binding site.
This calcium-dependence is unexpected, as the Bro1 domain
does not contain any known calcium-binding motif. Our data
suggest that calcium is coordinated by D97 and D178, two res-
idues in the vicinity of the LBPA-interaction loopwith orientations
consistent with those found in calcium-binding sites. ALIXBro1 in-
teractionswithmembranes appear to be reminiscent of annexins
andC2 domain-containing proteins (Gerke et al., 2005; Lemmon,
2008), which bind negatively chargedmembranes with a calcium
EC50 value in the low micromolar range (Evans and Nelsestuen,
1994; Guerrero-Valero et al., 2007). Annexins (Glenney, 1986)
and some C2 domains (Radhakrishnan et al., 2009), however,
exhibit a reduced capacity to bind calcium in the absence of
membranes, because calcium ions serve as a bridge between
protein and membrane. In contrast, ALIXBro1 appears to bind
calcium with a similar high affinity (EC50 < 1 mM), whether free
in solution (Figure 1E) or membrane-bound (Figure 1D), arguing
against the notion that calcium ions bound to ALIXBro1 link pro-
tein and membrane. The two residues, D97 and D178, are well
positioned to coordinate calcium at a site close to, but not in
immediate contact with the lipid headgroups—and calcium che-
lation does not release membrane-bound ALIXBro1. InteractionsDevelopmental Cell 25, 364–with the lipid headgroups likely involve
the basic residues on either side of the
lipid-binding motif.We conclude that calcium by binding close to the LBPA-inter-
action loop may stabilize or induce a change in the conformation
of the flexible loop favorable for membrane interaction (Fig-
ure S5). Docking of LBPA headgroup using the flexible docking
algorithm within the ICM molecular modeling package (Abagyan
and Totrov, 1994; Totrov and Abagyan, 1997, 2008) reveals that
it can be accommodated in a groove immediately above the
LBPA-interaction loop (Figures S5B and S5C). Upon membrane
interaction, ALIX would then undergo a local conformational
change leading to partial insertion of the hydrophobic loop into
the cytoplasmic leaflet of the bilayer.
ALIX in Viral Infection and Backfusion
Our data indicate that ALIX is recruited onto endosomes via
LBPA, where it can engage ESCRT-I and -III, and thereby regu-
lates viral nucleocapsid release. We also have evidence that
ALIX may dimerize upon membrane interaction, and that this
process is crucial for the role of ALIX in virus infection, as it is
for HIV budding (Pires et al., 2009). Interestingly, F105 in the
LBPA-interacting loop is also necessary for HIV release (Sette
et al., 2011; Zhai et al., 2011). It is attractive to speculate that
the trigger role of LBPA in causing ALIX conformational change
and dimerization is played by another component, presumably
a viral protein, during HIV budding. Importantly, ALIX-CHMP4373, May 28, 2013 ª2013 Elsevier Inc. 371
Developmental Cell
ALIX Lipid-Binding Module in Viral Infectioninteractions are dispensable for membrane targeting, but are
necessary for virus infection (this study), abscission during cyto-
kinesis (Carlton et al., 2008;Morita et al., 2007) and virus budding
(Usami et al., 2007). Thus one may hypothesize that ALIX coordi-
nates the assembly of CHMP4 filaments, which in turn contribute
to remodel the membrane.
This raises some key issues related to endosome topology, in
particular how ALIX, a cytosolic protein that is targeted to the
limiting membrane of late endosomes, controls the release of
viral RNA by regulating ILV backfusion. Although future work
will be necessary to determine precisely how this process is
regulated, our study already provides insights into the mecha-
nism at the molecular level.
ALIX and LBPAmay regulate backfusion indirectly, by control-
ling ILV formation (Falguie`res et al., 2008; Matsuo et al., 2004), as
both processes have to be tightly coupled in order to maintain
endosomal membrane homeostasis. Alternatively, it is also
possible that ALIX controls the backfusion process more
directly. We find that upon membrane binding ALIX undergoes
a conformation change that leads to the partial insertion of its
LBPA-interacting loop into the membrane. Insertion may affect
membrane symmetry, providing a mechanistic explanation for
ALIX effects on ILV formation in liposomes (Matsuo et al.,
2004) and endosomes (Falguie`res et al., 2008) in vitro. More
important, by affecting membrane symmetry, the partial inser-
tion of the hydrophobic loop into the cytoplasmic leaflet may
cause local perturbations of the bilayer organization, in concert
with ALIX dimerization, CHMP4 binding and assembly. The local
perturbation may, in turn, render the membrane more prone to
undergo fusion with ILVs on the lumenal side. This mechanism
would explain how ALIX, when binding to membranes, can con-
trol ILV backfusion and virus infection. These twomodels are not
mutually exclusive. In fact, one may speculate that ALIX and
LBPA formmicrodomains or hot spots on the endosomal limiting
membrane, where ILVs undergo kiss-and-run fusion and fission
cycles.
EXPERIMENTAL PROCEDURES
The protocols used for cell culture and transfection, as well as the list of
reagents, cDNA constructs, siRNAs, peptides, and recombinant proteins are
indicated in the Supplemental Experimental Procedures available online, as
are the detailed protocols we used in this study.
Production and Purification of Recombinant Proteins
Recombinant GST-ALIXBro1 and GST-MABP-myc were produced and purified
as described in the Supplemental Experimental Procedures.
Liposome-Binding Assays
Liposomes were prepared after lipid hydration and sonication at 0.3–3 mM free
calcium concentrations using calcium buffers. Liposomes containing LBPA
(DOPC/DOPE/PI/LBPA; [5:2:1:2 mol]) were incubated with ALIXBro1 in
25 mM HEPES-NaOH pH 7.4 containing 2 mM free calcium for 2 hr at 4C. In
some experiments, the mixture was supplemented with 100 mM peptide.
When indicated, liposomes without LBPA (DOPC/DOPE/PI at [7:2:1 mol]) or li-
posomes containing 90 mol% PC and 10 mol% of the designated lipid were
used. The liposome-bound protein was separated from free protein by floata-
tion in sucrose gradients. The liposome-protein mixture was adjusted to
40.6% sucrose, overlaid with 35% and 8.5% sucrose, and centrifuged for
1 hr at 55,000 rpm. Fractions of the 8.5% interphase, containing the liposomes,
the 35% sucrose cushion, and the load were collected and analyzed by west-
ern blotting.372 Developmental Cell 25, 364–373, May 28, 2013 ª2013 Elsevier InBiophysical Methods
The protocols used to measure isothermal titration calorimetry, Trp fluores-
cence, circular dichroism, and SAXS are available in the Supplemental
Experimental Procedures.
Immunofluorescence Analysis and Vesicular Stomatitis Virus
Infection
To study viral infection, cells were preincubatedwith VSV (1moi) for 1 hr at 4C,
and then for 3 hr at 37C. After fixation and permeabilization, cells were
analyzed by immunofluorescence using anti-VSV-G antibody, anti-myc
antibody (9E10) and DAPI for nuclei staining. In rescue experiments, siRNAs
were transfected 72 hr before infection and DNA was transfected 16 hr before
infection.
SUPPLEMENTAL INFORMATION
Supplemental Information includes five figures and Supplemental Experi-
mental Procedures and can be found with this article online at http://dx.doi.
org/10.1016/j.devcel.2013.04.003.
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